Anti-UGT3A1 antibody [EPR13723]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal UGT3A1 antibody. Suitable for IHC-P, IP, WB, ICC/IF and reacts with Human samples. Cited in 1 publication.
View Alternative Names
UDP-glucuronosyltransferase 3A1, UDPGT 3A1, UGT3A1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UGT3A1 antibody [EPR13723] (AB181245)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling UGT3A1 with ab181245 at a 1/100 dilution. Counter stained with hematoxylin. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UGT3A1 antibody [EPR13723] (AB181245)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling UGT3A1 with ab181245 at a 1/100 dilution. Counter stained with hematoxylin.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-UGT3A1 antibody [EPR13723] (AB181245)
Immunofluorescence analysis of paraformaldehyde-fixed HepG2 cells labeling UGT3A1 with ab181245 at a 1/500 dilution. As secondary antibody goat anti rabbit IgG (Alexa Fluor®555) was used at a 1/200. In blue DAPI staining.
- IP
Supplier Data
Immunoprecipitation - Anti-UGT3A1 antibody [EPR13723] (AB181245)
Western blot analysis on immunoprecipitation from 1) Human fetal liver lysate or 2) negative control, labeling UGT3A1 using ab181245 at 1/50 dilution and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG at a 1/1500 dilution.
All lanes:
Immunoprecipitation - Anti-UGT3A1 antibody [EPR13723] (ab181245)
Predicted band size: 59 kDa
Observed band size: 59 kDa
true
- WB
Supplier Data
Western blot - Anti-UGT3A1 antibody [EPR13723] (AB181245)
All lanes:
Western blot - Anti-UGT3A1 antibody [EPR13723] (ab181245) at 1/1000 dilution
Lane 1:
Human fetal liver lysate at 20 µg
Lane 2:
Human fetal kidney lysate at 20 µg
Lane 3:
Human testis lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab136636'>ab136636</a>) at 1/500 dilution
Predicted band size: 59 kDa
Observed band size: 59 kDa
true
- WB
Supplier Data
Western blot - Anti-UGT3A1 antibody [EPR13723] (AB181245)
All lanes:
Western blot - Anti-UGT3A1 antibody [EPR13723] (ab181245) at 1/1000 dilution
All lanes:
HepG2 cell lysate at 10 µg
Secondary
All lanes:
goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Predicted band size: 59 kDa
Observed band size: 59 kDa
true
Related conjugates and formulations (1)
-
Anti-UGT3A1 antibody [EPR13723] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This enzyme plays an important role in detoxification and metabolism processes. UGT3A1 is part of the larger UDP-glucuronosyltransferase family which participates in phase II of drug metabolism. It does not function individually but as a homodimer offering structural support for catalytic activity. By making hydrophobic molecules more water-soluble UGT3A1 reduces their biological activity and assists in their removal from the body maintaining homeostasis.
Pathways
UGT3A1 is integral to the glucuronidation pathway a critical phase II metabolic process. This pathway is essential for the clearance of a wide range of substrates including therapeutic drugs and endogenous substrates. UGT3A1 interacts with the cytochrome P450 family which primarily deal with phase I of drug metabolism. Together they constitute a comprehensive metabolic framework essential for biotransformation of many xenobiotics and endogenous substances.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 20:626 PubMed36578050
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com